Last updated: 2 July 2019 at 1:32am EST

Pharmaceuticals Ltd Satelli... Net Worth




The estimated Net Worth of Pharmaceuticals Ltd Satelli... is at least $132 Milione dollars as of 12 March 2014. Pharmaceuticals Satelli owns over 3,000,000 units of Novavax stock worth over $116,755,000 and over the last 11 years Pharmaceuticals sold NVAX stock worth over $14,850,000.

Pharmaceuticals Satelli NVAX stock SEC Form 4 insiders trading

Pharmaceuticals has made over 1 trades of the Novavax stock since 2014, according to the Form 4 filled with the SEC. Most recently Pharmaceuticals sold 3,000,000 units of NVAX stock worth $14,850,000 on 12 March 2014.

The largest trade Pharmaceuticals's ever made was selling 3,000,000 units of Novavax stock on 12 March 2014 worth over $14,850,000. On average, Pharmaceuticals trades about 3,000,000 units every 0 days since 2014. As of 12 March 2014 Pharmaceuticals still owns at least 9,500,000 units of Novavax stock.

You can see the complete history of Pharmaceuticals Satelli stock trades at the bottom of the page.



Insiders trading at Novavax

Over the last 23 years, insiders at Novavax have traded over $136,088,511 worth of Novavax stock and bought 2,908,869 units worth $5,634,467 . The most active insiders traders include David M Mott, Rajiv I. Modi e Gary C Evans. On average, Novavax executives and independent directors trade stock every 25 days with the average trade being worth of $907,678. The most recent stock trade was executed by John Trizzino on 19 August 2024, trading 655 units of NVAX stock currently worth $8,050.



What does Novavax do?

novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.



What does Novavax's logo look like?

Novavax, Inc. logo

Complete history of Pharmaceuticals Satelli stock trades at Novavax

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
12 Mar 2014 Pharmaceuticals Ltd Satelli...
Vendita 3,000,000 $4.95 $14,850,000
12 Mar 2014
9,500,000


Novavax executives and stock owners

Novavax executives and other stock owners filed with the SEC include: